A method of making the T cell vaccine for the treatment of multiple sclerosis comprising: (a) providing a sample comprising T cells (b) incubating the sample comprising T cells in the presence of a combination of the following synthetic peptides: (1) ENPVVHFFKNIVTPRTP (SEQ ID NO:l) (2) SKIFKLGGRDSRSGSPMARR (SEQ ID NO:2) (3) LFCGCGHEALTGTEKLIETY (SEQ ID NO:3) (4) WTTCQSIAFPSKTSASIGSL (SEQ ID NO:4) (5) GQFRVIGPRHPIRALVG (SEQ ID NO:5) and (6) EVELPCRISPGKNATGMEVGW (SEQ ID NO:6) (c) stimulating the cells of (b) with mitogen and (d) inactivating the cells of (c).